Dian Diagnostics Group Co.,Ltd.

SZSE:300244.SZ

22 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 13,362.28220,282.46913,082.61310,649.1628,453.2076,966.8575,004.1243,823.9811,858.1811,335.11,015.474706.419482.474343.273263.253178.29
Cost of Revenue 9,304.86712,745.8118,076.9496,578.7065,735.3994,595.13,332.1342,619.6371,233.461847.784638.651454.143314.211220.299170.167125.686
Gross Profit 4,057.4147,536.6595,005.6644,070.4562,717.8082,371.7571,671.991,204.344624.72487.316376.823252.276168.263122.97493.08652.605
Gross Profit Ratio 0.3040.3720.3830.3820.3220.340.3340.3150.3360.3650.3710.3570.3490.3580.3540.295
Reseach & Development Expenses 398.062638.474424.749319.104211.911166.265131.965101.16278.18257.01433.35322.55110.656000
General & Administrative Expenses 180.351270.882227.778205.658196.051187.387167.377118.52574.15155.70644.10132.71528.43153.20443.81821.152
Selling & Marketing Expenses 1,398.1121,597.0871,210.426966.374760.775648.651464.185326.827164.115134.381115.84279.11450.16833.42824.10216.448
SG&A 2,661.1581,867.9691,438.2041,172.032956.826836.038631.562445.352238.266190.087159.942111.8378.59986.63267.9237.6
Other Expenses -0.063961.484861.911564.857464.43812.67636.58319.10216.3012.6983.617-3.0282.6974.1130.718-0.478
Operating Expenses 3,059.2833,467.9262,724.8642,055.9931,633.1751,446.6161,115.625789.393430.244339.196268.003184.019125.54288.04170.39842.249
Operating Income 998.1323,814.9661,837.9352,077.0211,192.446721.398592.902415.852194.54150.217108.22971.59646.42533.85919.2716.975
Operating Income Ratio 0.0750.1880.140.1950.1410.1040.1180.1090.1050.1130.1070.1010.0960.0990.0730.039
Total Other Income Expenses Net -193.084-1,271.403-46.938-759.625-421.271-191.06773.12119.40215.9814.192.8295.0036.2652.927-2.73-3.883
Income Before Tax 805.0482,543.5621,790.9971,317.395771.175734.074629.486434.353210.457152.31111.64973.2648.98637.86119.9586.472
Income Before Tax Ratio 0.060.1250.1370.1240.0910.1050.1260.1140.1130.1140.110.1040.1020.110.0760.036
Income Tax Expense 216.735681.092307.396247.461195.607145.612165.39496.40331.67124.45721.61513.8667.4067.9464.741.968
Net Income 307.4611,434.1911,162.884802.933575.568388.608349.593262.761174.795124.58486.09360.18842.20832.41117.1696.59
Net Income Ratio 0.0230.0710.0890.0750.0680.0560.070.0690.0940.0930.0850.0850.0870.0940.0650.037
EPS 0.52.31.871.290.930.710.640.480.360.260.180.130.10.0960.0650.028
EPS Diluted 0.52.31.871.290.930.710.640.480.360.260.180.130.10.0960.0650.028
EBITDA 1,790.1064,614.4652,789.1562,369.9311,440.1461,186.681908.488540.067272.763184.097135.75990.8758.74246.06529.11113.855
EBITDA Ratio 0.1340.2280.2130.2230.170.170.1820.1410.1470.1380.1340.1290.1220.1340.1110.078